Literature DB >> 5297196

Retinal profiles. A psychophysical test of rod and cone sensitivity.

R D Gunkel.   

Abstract

Mesh：

Year:  1967        PMID： 5297196     DOI： 10.1001/archopht.1967.00980020024006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  7 in total

1.  Fundus-controlled two-color dark adaptometry with the Microperimeter MP1.

Authors:  Wadim Bowl; Knut Stieger; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-24       Impact factor: 3.117

2.  Spectral increment thresholds on a white background in different age groups of normal subjects and in acquired ocular diseases.

Authors:  G Verriest; A Uvijls
Journal:  Doc Ophthalmol       Date:  1977-06-30       Impact factor: 2.379

3.  Ophthalmological safety of chloroquine.

Authors:  S P Percival; J Behrman
Journal:  Br J Ophthalmol       Date:  1969-02       Impact factor: 4.638

4.  Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.

Authors:  S P Percival; I Meanock
Journal:  Br Med J       Date:  1968-09-07

5.  Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa.

Authors:  Lea D Bennett; Martin Klein; Kirsten G Locke; Kelly Kiser; David G Birch
Journal:  Transl Vis Sci Technol       Date:  2017-08-09       Impact factor: 3.283

6.  Disease Progression in Patients with Autosomal Dominant Retinitis Pigmentosa due to a Mutation in Inosine Monophosphate Dehydrogenase 1 (IMPDH1).

Authors:  Lea D Bennett; Martin Klein; Finny T John; Bojana Radojevic; Kaylie Jones; David G Birch
Journal:  Transl Vis Sci Technol       Date:  2020-04-23       Impact factor: 3.283

7.  The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene.

Authors:  David G Birch; Lassana Samarakoon; Michele Melia; Jacque L Duncan; Allison R Ayala; Isabelle Audo; Janet K Cheetham; Todd A Durham; Alessandro Iannaccone; Mark E Pennesi; Katarina Stingl
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.925
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.